Reshaping cardiac microenvironments by macrophage-derived extracellular vesicles-coated Pd@CeO 2 heterostructures for myocardial ischemia/reperfusion injury therapy
Bo Li,Qiang Zhang,Wenxian Du,Jianrong Wu,Jiahui Cheng,Yiming Zhang,Rifeng Gao,Xinxin Zhao,Lixian Jiang,Yingming Wu,Xiaojun Cai,Yuanyi Zheng,Yuehua Li,Yan Zhou
DOI: https://doi.org/10.1016/j.mattod.2023.03.024
IF: 24.2
2023-04-10
Materials Today
Abstract:Myocardial Ischemia/Reperfusion (MI/R) injury, a globally leading cause of mortality and disability, is commonly characterized by myriad inflammatory microenvironments, e.g. high level of reactive oxygen species (ROS), which has a high association with the consequent cell apoptosis and myocardial fibrosis. Herein, a reshaping strategy of cardiac microenvironments has been developed for relieving MI/R injury based on a biomimetic nanosystem ( 2 -M), which is composed of exterior macrophage-derived extracellular vesicles (MEVs) and encapsulated 2 heterostructures. Due to rapid electrons transfer on the interface, the 2 heterostructures exhibited outstanding ROS scavenging ability. The expression of Mac-1 and CD44 on the surface of 2 -M contributes to adsorbing to the inflamed endothelium and efficient cellular uptake within damaged cardiac microenvironments, thus allowing for inflammation-targeting ability. In the mouse model of MI/R injury, 2 -M accumulated and remained in the heart region over 24 hours. More importantly, 2 -M regulated immune response and promoted anti-apoptotic and anti-inflammatory processes via upregulating the PI3K/Akt signaling pathway and inhibiting the TLR4/p38MAPK and TLR4/NF-κB signaling pathways, dissipated interstitial edema, triggered prominent angiogenesis, and ultimately improved cardiac function and ventricular remodeling. Overall, the 2 -M heterostructures will provide an ideal paradigm of biomimetic nanomedicine confronting inflammatory diseases.
materials science, multidisciplinary